Wwp2 mediates Oct4 ubiquitination and its own auto-ubiquitination in a dosage-dependent manner

Cell Research

Volumn 20, Issue 3, 2010, Pages 332-344

  Liao, Bing ^a,b   Jin, Ying ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Auto ubiquitination; Degradation; Embryonal carcinoma cells; Oct4; Ubiquitin chain linkage; Wwp2

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4; RETINOIC ACID; UBIQUITIN PROTEIN LIGASE; WWP2 PROTEIN, MOUSE;

ANIMAL; ARTICLE; CELL DIFFERENTIATION; DIMERIZATION; GENE SILENCING; GENETICS; METABOLISM; MOUSE; RNA INTERFERENCE; TUMOR CELL LINE; UBIQUITINATION;

ANIMALS; CELL DIFFERENTIATION; CELL LINE, TUMOR; DIMERIZATION; GENE KNOCKDOWN TECHNIQUES; MICE; OCTAMER TRANSCRIPTION FACTOR-3; RNA INTERFERENCE; TRETINOIN; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 77949269474     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2009.136     Document Type: Article

References (51)

1. Scholer HR, Ruppert S, Suzuki N, Chowdhury K, Gruss P. New type of POU domain in germ line-specific protein Oct-4. Nature 1990; 344:435-439.
2. Palmieri SL, Peter W, Hess H, Scholer HR. Oct-4 transcription factor is differentially expressed in the mouse embryo during establishment of the first two extraembryonic cell lineages involved in implantation. Dev Biol 1994; 166:259-267.
3. Schoorlemmer J, Jonk L, Sanbing S, et al. Regulation of Oct- 4 gene expression during differentiation of EC cells. Mol Biol Rep 1995; 21:129-140.
4. Niwa H, Miyazaki J, Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or selfrenewal of ES cells. Nat Genet 2000; 24:372-376.
5. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126:663-676.
6. Kim JB, Sebastiano V, Wu G, et al. Oct4-induced pluripotency in adult neural stem cells. Cell 2009; 136:411-419.
7. Adhikary S, Marinoni F, Hock A, et al. The ubiquitin ligase HectH9 regulates transcriptional activation by Myc and is es sential for tumor cell proliferation. Cell 2005; 123:409-421.
8. Alexandru G, Graumann J, Smith GT, et al. UBXD7 binds multiple ubiquitin ligases and implicates p97 in HIF1alpha turnover. Cell 2008; 134:804-816.
9. Zhong Q, Gao W, Du F, Wang X. Mule/ARF-BP1, a BH3- only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell 2005; 121:1085-1095.
10. Melino G, Gallagher E, Aqeilan RI, et al. Itch: a HECT-type E3 ligase regulating immunity, skin and cancer. Cell Death Differ 2008; 15:1103-1112.
11. Dunn R, Klos DA, Adler AS, Hicke L. The C2 domain of the Rsp5 ubiquitin ligase binds membrane phosphoinositides and directs ubiquitination of endosomal cargo. J Cell Biol 2004; 165:135-144.
12. Huibregtse JM, Scheffner M, Beaudenon S, Howley PM. A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. Proc Natl Acad Sci USA 1995; 92:2563-2567.
13. Chen HI, Sudol M. The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules. Proc Natl Acad Sci USA 1995; 92:7819-7823.
14. Jennings MD, Blankley RT, Baron M, Golovanov AP, Avis JM. Specificity and autoregulation of Notch binding by tandem WW domains in suppressor of Deltex. J Biol Chem 2007; 282:29032-29042.
15. Sudol M, Recinos CC, Abraczinskas J, Humbert J, Farooq A. WW or WoW: the WW domains in a union of bliss. IUBMB Life 2005; 57:773-778.
16. Ingham RJ, Colwill K, Howard C, et al. WW domains provide a platform for the assembly of multiprotein networks. Mol Cell Biol 2005; 25:7092-7106.
17. Hershko A, Heller H, Elias S, Ciechanover A. Components of ubiquitin-protein ligase system. Resolution, affinity purification, and role in protein breakdown. J Biol Chem 1983; 258:8206-8214.
18. Ciechanover A. The ubiquitin-proteasome proteolytic pathway. Cell 1994; 79:13-21.
19. Hershko A. The ubiquitin system for protein degradation and some of its roles in the control of the cell division cycle. Cell Death Differ 2005; 12:1191-1197. (Pubitemid 41195103)
20. Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem 1998; 67:425-479.
21. Kim HT, Kim KP, Lledias F, et al. Certain pairs of ubiquitinconjugating enzymes (E2s) and ubiquitin-protein ligases (E3s) synthesize nondegradable forked ubiquitin chains containing all possible isopeptide linkages. J Biol Chem 2007; 282:17375-17386.
22. Hadari T, Warms JV, Rose IA, Hershko A. A ubiquitin Cterminal isopeptidase that acts on polyubiquitin chains. Role in protein degradation. J Biol Chem 1992; 267:719-727.
23. Brusky J, Zhu Y, Xiao W. UBC13, a DNA-damage-inducible gene, is a member of the error-free postreplication repair pathway in Saccharomyces cerevisiae. Curr Genet 2000; 37:168-174.
24. Wu CJ, Conze DB, Li T, Srinivasula SM, Ashwell JD. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-κB activation [corrected]. Nat Cell Biol 2006; 8:398-406.
25. Geetha T, Jiang J, Wooten MW. Lysine 63 polyubiquitination of the nerve growth factor receptor TrkA directs internalization and signaling. Mol Cell 2005; 20:301-312.
26. Shekhar MP, Gerard B, Pauley RJ, Williams BO, Tait L. Rad6B is a positive regulator of β-catenin stabilization. Cancer Res 2008; 68:1741-1750.
27. Hofmann RM, Pickart CM. In vitro assembly and recognition of Lys-63 polyubiquitin chains. J Biol Chem 2001; 276:27936-27943.
28. Nuber U, Schwarz SE, Scheffner M. The ubiquitin-protein ligase E6-associated protein (E6-AP) serves as its own substrate. Eur J Biochem 1998; 254:643-649.
29. Yang Y, Fang S, Jensen JP, Weissman AM, Ashwell JD. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science 2000; 288:874-877.
30. Bruce MC, Kanelis V, Fouladkou F, et al. Regulation of Nedd4-2 self-ubiquitination and stability by a PY motif located within its HECT-domain. Biochem J 2008; 415:155-163.
31. Lamothe B, Besse A, Campos AD, et al. Site-specific Lys-63- linked tumor necrosis factor receptor-associated factor 6 autoubiquitination is a critical determinant of I κB kinase activation. J Biol Chem 2007; 282:4102-4112.
32. Ben-Saadon R, Zaaroor D, Ziv T, Ciechanover A. The polycomb protein Ring1B generates self atypical mixed ubiquitin chains required for its in vitro histone H2A ligase activity. Mol Cell 2006; 24:701-711.
33. Xu HM, Liao B, Zhang QJ, et al. Wwp2, an E3 ubiquitin ligase that targets transcription factor Oct-4 for ubiquitination. J Biol Chem 2004; 279:23495-23503.
34. Pickart CM, Fushman D. Polyubiquitin chains: polymeric protein signals. Curr Opin Chem Biol 2004; 8:610-616.
35. Jin L, Williamson A, Banerjee S, Philipp I, Rape M. Mechanism of ubiquitin-chain formation by the human anaphasepromoting complex. Cell 2008; 133:653-665.
36. Hamazaki T, Oka M, Yamanaka S, Terada N. Aggregation of embryonic stem cells induces Nanog repression and primitive endoderm differentiation. J Cell Sci 2004; 117:5681-5686.
37. Miki K, Kitagawa Y. Biphasic response to retinoic acid dose in differentiation of F9 cells into primitive endoderm-like cells. Exp Cell Res 1988; 179:344-351.
38. Wiesner S, Ogunjimi AA, Wang HR, et al. Autoinhibition of the HECT-type ubiquitin ligase Smurf2 through its C2 domain. Cell 2007; 130:651-662.
39. Wu-Baer F, Lagrazon K, Yuan W, Baer R. The BRCA1/ BARD1 heterodimer assembles polyubiquitin chains through an unconventional linkage involving lysine residue K6 of ubiquitin. J Biol Chem 2003; 278:34743-34746.
40. Saeki Y, Kudo T, Sone T, et al. Lysine 63-linked polyubiquitin chain may serve as a targeting signal for the 26S proteasome. EMBO J 2009; 28:359-371.
41. Oberst A, Malatesta M, Aqeilan RI, et al. The Nedd4-binding partner 1 (N4BP1) protein is an inhibitor of the E3 ligase Itch. Proc Natl Acad Sci USA 2007; 104:11280-11285.
42. + channel cell surface expression. EMBO J 2001; 20:7052-7059.
43. Gao M, Labuda T, Xia Y, et al. Jun turnover is controlled through JNK-dependent phosphorylation of the E3 ligase Itch. Science 2004; 306:271-275.
44. Kee Y, Huibregtse JM. Regulation of catalytic activities of HECT ubiquitin ligases. Biochem Biophys Res Commun 2007; 354:329-333.
45. Woelk T, Oldrini B, Maspero E, et al. Molecular mechanisms of coupled monoubiquitination. Nat Cell Biol 2006; 8:1246-1254.
46. Pirozzi G, McConnell SJ, Uveges AJ, et al. Identification of novel human WW domain-containing proteins by cloning of ligand targets. J Biol Chem 1997; 272:14611-14616.
47. Ginis I, Luo Y, Miura T, et al. Differences between human and mouse embryonic stem cells. Dev Biol 2004; 269:360-380. (Pubitemid 38521104)
48. Leng RP, Lin Y, Ma W, et al. Pirh2, a p53-induced ubiquitinprotein ligase, promotes p53 degradation. Cell 2003; 112:779-791.
49. Li H, Zhang Z, Wang B, et al. Wwp2-mediated ubiquitination of the RNA polymerase II large subunit in mouse embryonic pluripotent stem cells. Mol Cell Biol 2007; 27:5296-5305.
50. Turksen K. Embryonic stem cells: Methods and Protocols. Totowa, NJ: Humana Press Inc, 2002.
51. Zhang Z, Liao B, Xu M, Jin Y. Post-translational modification of POU domain transcription factor Oct-4 by SUMO-1. FASEB J 2007; 21:3042-3051. (Pubitemid 47565525)